'Effects of the angiotensin-converting enzyme inhibitor perindopril on endothelial and platelet function in essential hypertension'

被引:9
作者
Jagroop, IA
Papadakis, JA
Mikhailidis, DP
机构
[1] Royal Free Hosp, Dept Chem Pathol & Human Metab, London NW3 2QG, England
[2] Sch Med, London NW3 2QG, England
关键词
D O I
10.1080/09537109876474
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:395 / 396
页数:2
相关论文
共 18 条
[1]   POTENTIAL USE OF ACE INHIBITORS AFTER ACUTE MYOCARDIAL-INFARCTION [J].
AMBROSIONI, E ;
BORGHI, C .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 14 :S92-S94
[2]   EFFECTS OF DIFFERENT ANTIHYPERTENSIVE DRUGS ON PLASMA-FIBRINOGEN IN HYPERTENSIVE PATIENTS [J].
FOGARI, R ;
ZOPPI, A ;
MALAMANI, GD ;
MARASI, G ;
VANASIA, A ;
VILLA, G .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (05) :471-476
[3]  
FOGARI R, 1997, 4 INT S MULT RISK FA
[4]   A LACK OF EFFECT OF CAPTOPRIL ON PLATELET-AGGREGATION IN PATIENTS WITH CONGESTIVE-HEART-FAILURE [J].
GOW, IF ;
FLAPAN, AD ;
MORRIS, M ;
DAVIES, E ;
WILLIAMS, BC ;
PADFIELD, PL ;
SHAW, TRD ;
EDWARDS, CRW .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 41 (01) :47-49
[5]  
JAGROOP IA, 1997, PHARMACOLOGIST, V39, P24
[6]  
JAMES IM, 1988, J HUM HYPERTENS, V2, P21
[7]   Fosinopril reduces ADP-Induced platelet aggregation in hypertensive patients [J].
Keidar, S ;
Oiknine, J ;
Leiba, A ;
Shapira, C ;
Leiba, M ;
Aviram, M .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 27 (02) :183-186
[8]   Metabolic effects of long term treatments with nifedipine-retard and captopril in young hypertensive patient [J].
Masuo, K ;
Mikami, H ;
Ogihara, T ;
Tuck, ML .
AMERICAN JOURNAL OF HYPERTENSION, 1997, 10 (06) :600-610
[9]   EPIDEMIOLOGICAL CHARACTERISTICS OF PLATELET AGGREGABILITY [J].
MEADE, TW ;
VICKERS, MV ;
THOMPSON, SG ;
STIRLING, Y ;
HAINES, AP ;
MILLER, GJ .
BRITISH MEDICAL JOURNAL, 1985, 290 (6466) :428-432
[10]   ACE inhibitor effects on platelet function in stages I-II hypertension [J].
Moser, L ;
Callahan, KS ;
Cheung, AK ;
Stoddard, GJ ;
Munger, MA .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1997, 30 (04) :461-467